These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Effect of pranlukast on neonatal rats with periventricular leukomalacia]. Author: Ye XY, Wang DY, Xu Y, Wang J. Journal: Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jun; 22(6):656-661. PubMed ID: 32571468. Abstract: OBJECTIVE: To study the effect of pranlukast (Pran) on neonatal rats with periventricular leukomalacia (PVL). METHODS: The rats, aged 3 days, were randomly divided into a sham-operation group, a PVL group, and a Pran group. A rat model of PVL was prepared by right common carotid artery ligation and postoperative hypoxia. The rats in the sham-operation group were given isolation of the right common carotid artery without ligation or hypoxic treatment. The rats in the Pran group were given intraperitoneal injection of Pran (0.1 mg/kg) once every 12 hours, for 3 consecutive days, and those in the sham-operation group and the PVL group were given intraperitoneal injection of an equal volume of normal saline. On day 14 after modeling, hematoxylin-eosin (HE) staining was used to observe the pathological changes of brain tissue; immunofluorescent staining was used to measure the expression of myelin basic protein (MBP) in brain tissue (n=8); Western blot was used to measure the expression of cyclic nucleotide phosphodiesterase (CNPase), MBP, and G protein-coupled receptor 17 (GPR17) (n=8). On day 21 after modeling, Morris water maze test was used to evaluate the learning and memory abilities of rats in each group (n=8). RESULTS: The results of HE staining showed that the PVL group had greater pathological changes of white matter than the sham-operation group, and compared with the PVL group, the Pran group had a significant improvement in such pathological changes. The results of immunofluorescence assay showed that the PVL group had a lower mean fluorescence intensity of MBP than the sham-operation group (P<0.05), and the Pran group had a higher mean fluorescence intensity of MBP than the PVL group (P<0.05). Western blot showed that compared with the sham-operation group, the PVL group had significantly lower relative expression of MBP and CNPase (P<0.05) and significantly higher relative expression of GPR17 (P<0.05), and compared with the PVL group, the Pran group had significantly higher relative expression of MBP and CNPase (P<0.05) and significantly lower relative expression of GPR17 (P<0.05). Morris water maze test showed that compared with the sham-operation group, the PVL group had a significant increase in escape latency and a significant reduction in the number of platform crossings, and compared with the PVL group, the Pran group had a significant reduction in escape latency and a significant increase in the number of platform crossings (P<0.05). CONCLUSIONS: Pran can alleviate brain damage, promote myelination, and improve long-term learning and memory abilities in neonatal rats with PVL, possibly by reducing the expression of GPR17. 目的: 探讨普仑司特(Pran)对脑室周围白质软化(PVL)新生大鼠的作用。 方法: 将3日龄大鼠随机分为假手术(Sham)组、PVL组和Pran组。通过右侧颈总动脉结扎及术后缺氧建立PVL模型,Sham组大鼠仅游离右侧颈总动脉,不予结扎,也不进行缺氧处理。Pran组缺氧后经腹腔注射Pran(0.1 mg/kg),每12 h注射1次,连续注射3 d,Sham组和PVL组分别给予等量生理盐水腹腔注射。造模后14 d,通过苏木精-伊红染色法观察脑组织病理变化,免疫荧光染色法检测脑组织髓鞘碱性蛋白(MBP)表达(n=8),免疫印迹法测定环核苷酸磷酸二酯酶(CNPase)、MBP和G蛋白偶联受体17(GPR17)表达(n=8)。造模后21 d,应用Morris水迷宫实验评价各组大鼠的学习记忆能力(n=8)。 结果: HE染色结果表明:PVL组与Sham组比较脑白质出现明显病理性改变,Pran组病理变化较PVL组明显改善。免疫荧光结果显示:PVL组MBP平均荧光强度低于Sham组,Pran组MBP平均荧光强度高于PVL组(P < 0.05)。Western blot结果显示:PVL组MBP和CNPase蛋白相对表达均低于Sham组,GPR17蛋白相对表达高于Sham组(P < 0.05);Pran组MBP和CNPase蛋白相对表达均高于PVL组,GPR17蛋白相对表达低于PVL组(P < 0.05)。Morris水迷宫实验结果显示:PVL组与Sham组比较,逃避潜伏期延长,穿越平台次数减少;Pran组与PVL组比较,逃避潜伏期缩短,穿越平台次数增加(P < 0.05)。 结论: Pran可减轻PVL新生大鼠的脑损伤,促进髓鞘形成,改善远期学习记忆能力。其作用机制可能与下调GPR17的表达有关。[Abstract] [Full Text] [Related] [New Search]